BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Loprinzi CL, Lacchetti C, Bleeker J, Cavaletti G, Chauhan C, Hertz DL, Kelley MR, Lavino A, Lustberg MB, Paice JA, Schneider BP, Lavoie Smith EM, Smith ML, Smith TJ, Wagner-Johnston N, Hershman DL. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. J Clin Oncol 2020;38:3325-48. [PMID: 32663120 DOI: 10.1200/JCO.20.01399] [Cited by in Crossref: 220] [Cited by in F6Publishing: 235] [Article Influence: 73.3] [Reference Citation Analysis]
Number Citing Articles
1 Guo S, Han W, Wang P, Wang X, Fang X. Effects of exercise on chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review and meta-analysis. J Cancer Surviv 2023;17:318-31. [PMID: 35149899 DOI: 10.1007/s11764-022-01182-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
2 Itoh K, Shimoyama M, Schiller PW, Toyama S. Protective effect of a mitochondria-targeting peptide against paclitaxel-induced peripheral neuropathy. Chem Biol Drug Des 2023;101:1012-8. [PMID: 36513390 DOI: 10.1111/cbdd.14192] [Reference Citation Analysis]
3 Kanda K, Ishida K, Kyota A, Ishihara C, Fujimoto K, Hosokawa M, Mochizuki R. Randomized clinical trial quantifying the effectiveness of a self-monitoring intervention in cancer patients with peripheral neuropathy: A quantitative study. Asia Pac J Oncol Nurs 2023;10:100198. [PMID: 36949819 DOI: 10.1016/j.apjon.2023.100198] [Reference Citation Analysis]
4 Shinouchi R, Sasaki A, Takaki T, Tsuji M, Kiuchi Y, Nobe K. The effect of hand therapy on alleviating chemotherapy-induced peripheral neuropathy in a model mouse. Neurosci Lett 2023;800:137138. [PMID: 36813075 DOI: 10.1016/j.neulet.2023.137138] [Reference Citation Analysis]
5 Szklener K, Rudzińska A, Juchaniuk P, Kabała Z, Sławomir Mańdziuk. Ozone in Chemotherapy-Induced Peripheral Neuropathy—Current State of Art, Possibilities, and Perspectives. IJMS 2023;24:5279. [DOI: 10.3390/ijms24065279] [Reference Citation Analysis]
6 Becker G, Fialho MFP, Brusco I, Oliveira SM. Kinin B1 and B2 Receptors Contribute to Cisplatin-Induced Painful Peripheral Neuropathy in Male Mice. Pharmaceutics 2023;15:852. [DOI: 10.3390/pharmaceutics15030852] [Reference Citation Analysis]
7 Chow R, Novosel M, So OW, Bellampalli S, Xiang J, Boldt G, Winquist E, Lock M, Lustberg M, Prsic E. Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis. BMJ Support Palliat Care 2023;13:27-34. [PMID: 36194493 DOI: 10.1136/spcare-2022-003815] [Reference Citation Analysis]
8 Ling F, Qi W, Li X, Zhou J, Xiong J, Zhao Y, Zheng Q, Liang F. Bibliometric Analysis of Acupuncture Therapy for Cancer Pain Over the Past 10 Years. JPR 2023;Volume 16:985-1003. [DOI: 10.2147/jpr.s395421] [Reference Citation Analysis]
9 Knoerl R, Wallar J, Fox E, Hong F, Salehi E, McCleary N, Ligibel JA, Reyes K, Berry DL. Exploring Clinicians' Perspectives of Barriers to Chemotherapy-Induced Peripheral Neuropathy Assessment and Management in Oncology Practice: A Qualitative Analysis of Semi-structured Interviews. Cancer Nurs 2023;46:103-10. [PMID: 35283473 DOI: 10.1097/NCC.0000000000001082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mio Pos A, Wainstein AJA, Aleixo M, Vieira BAS, Drummond-Lage AP. Pain Treatment and Cancer Patients: Are we Heeding Quality of Life? J Pain Palliat Care Pharmacother 2023;37:63-71. [PMID: 36630265 DOI: 10.1080/15360288.2022.2155755] [Reference Citation Analysis]
11 Atkins SLP, Zimmer AS. Neurologic complications of breast cancer. Cancer 2023;129:505-20. [PMID: 36537474 DOI: 10.1002/cncr.34518] [Reference Citation Analysis]
12 Kume M, Ahmad A, Defea KA, Vagner J, Dussor G, Boitano S, Price TJ. Protease-Activated Receptor 2 (PAR2) expressed in sensory neurons contributes to signs of pain and neuropathy in paclitaxel treated mice.. [DOI: 10.1101/2023.02.12.528175] [Reference Citation Analysis]
13 Lu C, Li G, Deng D, Li R, Li X, Feng X, Wu T, Shao X, Chen W. Efficacy of electroacupuncture in the treatment of peripheral neuropathy caused by Utidelone: Study protocol for a randomized controlled trial. Front Neurol 2023;14:1065635. [PMID: 36846114 DOI: 10.3389/fneur.2023.1065635] [Reference Citation Analysis]
14 Mortensen C, Chua KC, Hammer HS, Nielsen F, Pötz O, Svenningsen ÅF, Kroetz DL, Stage TB. Paclitaxel- and vincristine-induced neurotoxicity and drug transport in sensory neurons.. [DOI: 10.1101/2023.02.07.527432] [Reference Citation Analysis]
15 Côté J, Kotb R, Bergstrom DJ, LeBlanc R, Mian HS, Othman I, Louzada ML. First Line Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma: Recommendations from the Canadian Myeloma Research Group Consensus Guideline Consortium. Clin Lymphoma Myeloma Leuk 2023:S2152-2650(23)00035-6. [PMID: 36925389 DOI: 10.1016/j.clml.2023.01.016] [Reference Citation Analysis]
16 Brianna, Lee SH. Chemotherapy: how to reduce its adverse effects while maintaining the potency? Med Oncol 2023;40:88. [PMID: 36735206 DOI: 10.1007/s12032-023-01954-6] [Reference Citation Analysis]
17 Park KT, Jo H, Kim B, Kim W. Red Ginger Extract Prevents the Development of Oxaliplatin-Induced Neuropathic Pain by Inhibiting the Spinal Noradrenergic System in Mice. Biomedicines 2023;11. [PMID: 36830967 DOI: 10.3390/biomedicines11020432] [Reference Citation Analysis]
18 Capela A, Alonso R, Araújo A, Craveiro-Lopes B, Fragoso RM, Mansinho H, Moutinho R, Teixeira JA, Vieira C, Veiga D. [Chemotherapy-Induced Peripheral Neuropathic Pain in Cancer Patients/Survivors]. Acta Med Port 2023;36:77-80. [PMID: 36738187 DOI: 10.20344/amp.18750] [Reference Citation Analysis]
19 Li T, Timmins HC, Trinh T, Mizrahi D, Harrison M, Horvath LG, Grimison P, Friedlander M, Kiernan MC, King MT, Rutherford C, Goldstein D, Park SB. Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important Changes. J Natl Compr Canc Netw 2023;21:125-132.e3. [PMID: 36791763 DOI: 10.6004/jnccn.2022.7074] [Reference Citation Analysis]
20 Iseppon F, Luiz AP, Linley JE, Wood JN. Pregabalin Silences Oxaliplatin-Activated Sensory Neurons to Relieve Cold Allodynia. eNeuro 2023;10:ENEURO. [PMID: 36720644 DOI: 10.1523/ENEURO.0395-22.2022] [Reference Citation Analysis]
21 Cathcart-Rake EJ, Ruddy KJ. Evidence-Based Guidance for Breast Cancer Survivorship. Hematol Oncol Clin North Am 2023;37:225-43. [PMID: 36435612 DOI: 10.1016/j.hoc.2022.08.019] [Reference Citation Analysis]
22 Decker V, King C, Cassisi J, Tofthagen C. Usability and Acceptability of a Videoconference Program for the Treatment of Depression in Adults With Peripheral Neuropathy. Comput Inform Nurs 2023. [PMID: 36719756 DOI: 10.1097/CIN.0000000000001008] [Reference Citation Analysis]
23 Klafke N, Bossert J, Kröger B, Neuberger P, Heyder U, Layer M, Winkler M, Idler C, Kaschdailewitsch E, Heine R, John H, Zielke T, Schmeling B, Joy S, Mertens I, Babadag-Savas B, Kohler S, Mahler C, Witt CM, Steinmann D, Voiss P, Stolz R. Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy (CIPN) with Non-Pharmacological Interventions: Clinical Recommendations from a Systematic Scoping Review and an Expert Consensus Process. Med Sci (Basel) 2023;11. [PMID: 36810482 DOI: 10.3390/medsci11010015] [Reference Citation Analysis]
24 Li X, Zhi L, Han KY, Li SQ, Ahmad K, Seluzicki C, Wang R, Bao T. Impact of Baseline Expectancy on Outcome Prediction of Real and Sham Acupuncture for Persistent Chemotherapy-Induced Peripheral Neuropathy Pain in Solid Tumor Survivors: A Secondary Analysis of a Randomized Clinical Trial. Integr Cancer Ther 2023;22:15347354221149992. [PMID: 36691937 DOI: 10.1177/15347354221149992] [Reference Citation Analysis]
25 Matesanz-García L, Billerot C, Fundaun J, Schmid AB. Effect of Type and Dose of Exercise on Neuropathic Pain After Experimental Sciatic Nerve Injury: A Preclinical Systematic Review and Meta-Analysis. J Pain 2023:S1526-5900(23)00019-6. [PMID: 36690283 DOI: 10.1016/j.jpain.2023.01.011] [Reference Citation Analysis]
26 Wu J, Li Y, He Q, Yang X. Exploration of the Use of Natural Compounds in Combination with Chemotherapy Drugs for Tumor Treatment. Molecules 2023;28. [PMID: 36770689 DOI: 10.3390/molecules28031022] [Reference Citation Analysis]
27 Clavo B, Cánovas-Molina A, Ramallo-Fariña Y, Federico M, Rodríguez-Abreu D, Galván S, Ribeiro I, Marques da Silva SC, Navarro M, González-Beltrán D, Díaz-Garrido JA, Cazorla-Rivero S, Rodríguez-Esparragón F, Serrano-Aguilar P. Effects of Ozone Treatment on Health-Related Quality of Life and Toxicity Induced by Radiotherapy and Chemotherapy in Symptomatic Cancer Survivors. Int J Environ Res Public Health 2023;20. [PMID: 36674232 DOI: 10.3390/ijerph20021479] [Reference Citation Analysis]
28 Kheshti R, Dehghani M, Namazi S, Firouzabadi D, Mahmoudi L, Haem E. Effect of melatonin on oxaliplatin induced neuropathy in patients receiving FOLFOX and XELOX chemotherapy regimens for stage II-IV colorectal cancer; A randomized, placebo controlled, double blind trial.. [DOI: 10.21203/rs.3.rs-2428741/v1] [Reference Citation Analysis]
29 Saito K, Koizumi S. A promising drug for neuropathic pain: identification of vesicular nucleotide transporter as a novel target of eicosapentaenoic acid. Purinergic Signal 2023. [PMID: 36627401 DOI: 10.1007/s11302-022-09918-7] [Reference Citation Analysis]
30 Chan H, Savoie MB, Munir A, Moslehi J, Anwar M, Laffan A, Rowen T, Salmon R, Varma M, Van Loon K. Multi-Disciplinary Management in Rectal Cancer Survivorship: A Clinical Practice Review. J Gastrointest Cancer 2023. [PMID: 36622517 DOI: 10.1007/s12029-022-00885-1] [Reference Citation Analysis]
31 Takeshita AA, Hammock BD, Wagner KM. Soluble epoxide hydrolase inhibition alleviates chemotherapy induced neuropathic pain. Front Pain Res (Lausanne) 2022;3:1100524. [PMID: 36700145 DOI: 10.3389/fpain.2022.1100524] [Reference Citation Analysis]
32 Chai Y, Zhao F, Ye P, Ma F, Wang J, Zhang P, Li Q, Wang J, Wang W, Li Q, Xu B. A Prospective, Randomized, Placebo-Controlled Study Assessing the Efficacy of Chinese Herbal Medicine (Huangqi Guizhi Wuwu Decoction) in the Treatment of Albumin-Bound Paclitaxel-Induced Peripheral Neuropathy. J Clin Med 2023;12. [PMID: 36675434 DOI: 10.3390/jcm12020505] [Reference Citation Analysis]
33 Bienfait F, Julienne A, Jubier-Hamon S, Seegers V, Delorme T, Jaoul V, Pluchon YM, Lebrec N, Dupoiron D. Evaluation of 8% Capsaicin Patches in Chemotherapy-Induced Peripheral Neuropathy: A Retrospective Study in a Comprehensive Cancer Center. Cancers (Basel) 2023;15. [PMID: 36672298 DOI: 10.3390/cancers15020349] [Reference Citation Analysis]
34 Seretny M, Romaniuk L, Whalley H, Sladdin K, Lawrie S, Warnaby CE, Roberts N, Colvin L, Tracey I, Fallon M. Neuroimaging reveals a potential brain-based pre-existing mechanism that confers vulnerability to development of chronic painful chemotherapy-induced peripheral neuropathy. Br J Anaesth 2023;130:83-93. [PMID: 36396483 DOI: 10.1016/j.bja.2022.09.026] [Reference Citation Analysis]
35 Shin GJ. Towards a mechanistic understanding of axon transport and endocytic changes underlying paclitaxel-induced peripheral neuropathy. Exp Neurol 2023;359:114258. [PMID: 36279934 DOI: 10.1016/j.expneurol.2022.114258] [Reference Citation Analysis]
36 Sanati V, Sohouli MH, Dareini H, Esmailzadeh A, Sajadian AS, Raji Lahiji M, Clark CCT, Zarrati M. The Association between Dietary Patterns and Chemotherapy Side Effects in Patients with Breast Cancer (BrCa). Nutr Cancer 2023;75:948-59. [PMID: 36734527 DOI: 10.1080/01635581.2023.2173552] [Reference Citation Analysis]
37 Paul C, Custodio CM. Neuropathy in Lung Cancer. Lung Cancer Rehabilitation 2023. [DOI: 10.1016/b978-0-323-83404-9.00007-4] [Reference Citation Analysis]
38 Noya-Riobó MV, Miguel CÁ, Soriano DB, Brumovsky PR, Villar MJ, Coronel MF. Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences. Exp Neurol 2023;359:114232. [PMID: 36179876 DOI: 10.1016/j.expneurol.2022.114232] [Reference Citation Analysis]
39 Gu J, Hu M, Wang X, Ji Y, Li L, Yu J, Hu C, Ni J, Wei G, Huo J. Data mining analysis reveals key acupoints and meridians for the treatment of chemotherapy-induced peripheral neuropathy. Explore (NY) 2023;19:71-7. [PMID: 35437224 DOI: 10.1016/j.explore.2022.04.003] [Reference Citation Analysis]
40 Peipert JD, Shaunfield S, Kaiser K, Moreno PI, Fox RS, Kircher S, Mohindra N, Ip E, Zhao F, Wagner L, Cella D. How do patients interpret and respond to a single-item global indicator of cancer treatment tolerability? Support Care Cancer 2023;31:37. [DOI: 10.1007/s00520-022-07484-7] [Reference Citation Analysis]
41 Bagüés A, Benítez D, Abalo R. Cannabinoids to Fight Chemotherapy-Induced Adverse Effects. Handbook of Cancer and Immunology 2023. [DOI: 10.1007/978-3-030-80962-1_350-1] [Reference Citation Analysis]
42 Chen CS, Hertz DL. Chemotherapy-Induced Peripheral Neuropathy. Handb Exp Pharmacol 2023;277:299-337. [PMID: 36253554 DOI: 10.1007/164_2022_609] [Reference Citation Analysis]
43 Zhai J, Sun X, Zhao F, Pan B, Li H, Lv Z, Cao M, Zhao J, Mo H, Ma F, Xu B. Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study. Breast 2023;67:36-45. [PMID: 36586272 DOI: 10.1016/j.breast.2022.12.034] [Reference Citation Analysis]
44 Wang C, Chen S, Jiang W. Treatment for chemotherapy-induced peripheral neuropathy: A systematic review of randomized control trials. Front Pharmacol 2022;13:1080888. [PMID: 36618919 DOI: 10.3389/fphar.2022.1080888] [Reference Citation Analysis]
45 Li X, Sun Q, Ding H, Hao S, Lan Y, Liu L, Wang R. A randomized controlled study of a combination of internal and external treatments for albumin paclitaxel-related peripheral neurotoxicity: A randomized controlled: A study protocol. Medicine (Baltimore) 2022;101:e32252. [PMID: 36595835 DOI: 10.1097/MD.0000000000032252] [Reference Citation Analysis]
46 Lv X, Mao Y, Cao S, Feng Y. Animal models of chemotherapy‐induced peripheral neuropathy for hematological malignancies: A review. Ibrain 2022. [DOI: 10.1002/ibra.12086] [Reference Citation Analysis]
47 Ben-Arye E, Gamus D, Samuels N, Schiff E, Hausner D, Gressel O, Attias S, Lavie O, David A, Shulman K, Agbarya A. Acupuncture and integrative oncology for taxane-induced peripheral neuropathy: a randomized multicentered study. Int J Gynecol Cancer 2022:ijgc-2022-004004. [PMID: 36600535 DOI: 10.1136/ijgc-2022-004004] [Reference Citation Analysis]
48 Alberti P, Salvalaggio A, Argyriou AA, Bruna J, Visentin A, Cavaletti G, Briani C. Neurological Complications of Conventional and Novel Anticancer Treatments. Cancers (Basel) 2022;14. [PMID: 36551575 DOI: 10.3390/cancers14246088] [Reference Citation Analysis]
49 Mortensen C, Steffensen KD, Simonsen E, Herskind K, Madsen JS, Olsen DA, Iversen DB, Bergmann TK, Pottegård A, Stage TB. Neurofilament light chain as a biomarker of axonal damage in sensory neurons and paclitaxel-induced peripheral neuropathy in patients with ovarian cancer. Pain 2022. [PMID: 36508173 DOI: 10.1097/j.pain.0000000000002840] [Reference Citation Analysis]
50 Klazas M, Naamneh MS, Zheng W, Lazarovici P. Gabapentin Increases Intra-Epidermal and Peptidergic Nerve Fibers Density and Alleviates Allodynia and Thermal Hyperalgesia in a Mouse Model of Acute Taxol-Induced Peripheral Neuropathy. Biomedicines 2022;10. [PMID: 36551946 DOI: 10.3390/biomedicines10123190] [Reference Citation Analysis]
51 Hooshmand K, Goldstein D, Timmins HC, Li T, Harrison M, Friedlander ML, Lewis CR, Lees JG, Moalem-Taylor G, Guennewig B, Park SB, Kwok JB. Polygenic risk of paclitaxel-induced peripheral neuropathy: a genome-wide association study. J Transl Med 2022;20:564. [PMID: 36474270 DOI: 10.1186/s12967-022-03754-4] [Reference Citation Analysis]
52 Cabañero D, Villalba-Riquelme E, Fernández-Ballester G, Fernández-Carvajal A, Ferrer-Montiel A. ThermoTRP channels in pain sexual dimorphism: new insights for drug intervention. Pharmacol Ther 2022;240:108297. [PMID: 36202261 DOI: 10.1016/j.pharmthera.2022.108297] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Chan A, Elsayed A, Ng DQ, Ruddy K, Loprinzi C, Lustberg M. A global survey on the utilization of cryotherapy and compression therapy for the prevention of chemotherapy-induced peripheral neuropathy. Support Care Cancer 2022;30:10001-7. [PMID: 36214880 DOI: 10.1007/s00520-022-07383-x] [Reference Citation Analysis]
54 Oliveira HR, Coelho MS, Neves FDAR, Duarte DB. Cisplatin-induced changes in calcitonin gene-related peptide or TNF-α release in rat dorsal root ganglia in vitro model of neurotoxicity are not reverted by rosiglitazone. NeuroToxicology 2022;93:211-221. [DOI: 10.1016/j.neuro.2022.10.002] [Reference Citation Analysis]
55 Mao JJ, Ismaila N, Bao T, Barton D, Ben-Arye E, Garland EL, Greenlee H, Leblanc T, Lee RT, Lopez AM, Loprinzi C, Lyman GH, MacLeod J, Master VA, Ramchandran K, Wagner LI, Walker EM, Bruner DW, Witt CM, Bruera E. Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology-ASCO Guideline. J Clin Oncol 2022;40:3998-4024. [PMID: 36122322 DOI: 10.1200/JCO.22.01357] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
56 Navia-Pelaez JM, Paes Lemes JB, Gonzalez L, Delay L, Capettini LDSA, Lu JW, Dos Santos GG, Gregus AM, Dougherty PM, Yaksh TL, Miller YI. AIBP regulates TRPV1 activation in CIPN by controlling lipid raft dynamics and proximity to TLR4 in DRG neurons. Pain 2022. [PMID: 36719418 DOI: 10.1097/j.pain.0000000000002834] [Reference Citation Analysis]
57 Kanzawa-Lee G, Knoerl R. What do the data say about chemotherapy-induced peripheral neuropathy assessment and management? Asia Pac J Oncol Nurs 2023;10:100170. [PMID: 36593974 DOI: 10.1016/j.apjon.2022.100170] [Reference Citation Analysis]
58 Housley SN, Nardelli P, Rotterman TM, Reed J, Cope TC. Mechanosensory encoding dysfunction emerges from cancer-chemotherapy interaction. Front Mol Biosci 2022;9:1017427. [PMID: 36504708 DOI: 10.3389/fmolb.2022.1017427] [Reference Citation Analysis]
59 Lee JH, Choi JH, Kim J, Kim TW, Kim JY, Chung G, Cho IH, Jang DS, Kim SK. Syringaresinol Alleviates Oxaliplatin-Induced Neuropathic Pain Symptoms by Inhibiting the Inflammatory Responses of Spinal Microglia. Molecules 2022;27. [PMID: 36500231 DOI: 10.3390/molecules27238138] [Reference Citation Analysis]
60 Aghabozorgi R, Hesam M, Zahed G, Babaee M, Hashemi M, Rayegani SM. Efficacy of Duloxetine on electrodiagnostic findings of Paclitaxel-induced peripheral neuropathy, does it have a prophylactic effect? A randomized clinical trial. Anticancer Drugs 2022. [PMID: 36730548 DOI: 10.1097/CAD.0000000000001429] [Reference Citation Analysis]
61 Mori K, Kawashiri T, Mine K, Inoue M, Kudamatsu H, Uchida M, Egashira N, Kobayashi D, Shimazoe T. Inhibitory Effect of α1 Receptor Antagonists on Paclitaxel-Induced Peripheral Neuropathy in a Rodent Model and Clinical Database. Toxics 2022;10. [PMID: 36355960 DOI: 10.3390/toxics10110669] [Reference Citation Analysis]
62 Martineau C, Turcotte M, Otis N, Provost F, Themens L, Guay M, Letarte N, Adam J. Management of adverse events related to first-generation tyrosine receptor kinase inhibitors in adults: a narrative review. Support Care Cancer 2022. [DOI: 10.1007/s00520-022-07401-y] [Reference Citation Analysis]
63 Davis M, Loprinzi C. Pregabalin for chemotherapy-induced neuropathy: background and rationale for further study. Support Care Cancer 2022;30:8845-53. [PMID: 35953729 DOI: 10.1007/s00520-022-07317-7] [Reference Citation Analysis]
64 Nepal MR, Taheri H, Li Y, Talebi Z, Uddin ME, Jin Y, DiGiacomo DF, Gibson AA, Lustberg MB, Hu S, Sparreboom A. Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neurotoxicity. Cancer Res Commun 2022;2:1334-43. [PMID: 36506732 DOI: 10.1158/2767-9764.crc-22-0172] [Reference Citation Analysis]
65 Pfeiffer P, Lustberg M, Näsström J, Carlsson S, Persson A, Nagahama F, Cavaletti G, Glimelius B, Muro K. Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M). JNCI Cancer Spectr 2022;6. [PMID: 36308441 DOI: 10.1093/jncics/pkac075] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
66 Tanay MAL, Armes J, Oakley C, Bryson L, Johnston R, Moss-Morris R, Rafferty AM, Roca J, Sage L, Tanner D, Urwin L, Wyatt T, Robert G. Co-designing a behavioural intervention for reducing the impact of chemotherapy-induced peripheral neuropathy symptoms: An evidence- and theory-driven approach. Eur J Cancer Care (Engl) 2022;31:e13671. [PMID: 35959639 DOI: 10.1111/ecc.13671] [Reference Citation Analysis]
67 Chen J, Yan M, Huang K, Xue J. Novel molecular photosensitizer with simultaneously GSH depletion, aggregation inhibition and accelerated elimination for improved and safe photodynamic therapy. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114938] [Reference Citation Analysis]
68 Heidari S, Kargar M. Effects of vitamin E in preventing taxane‑induced peripheral neuropathy. Cancer Chemother Pharmacol 2022. [PMID: 36197465 DOI: 10.1007/s00280-022-04475-7] [Reference Citation Analysis]
69 Xu Z, Wang X, Wu Y, Wang C, Fang X. The effectiveness and safety of acupuncture for chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Front Neurol 2022;13:963358. [DOI: 10.3389/fneur.2022.963358] [Reference Citation Analysis]
70 Fahrig L, Zander T, Alakus H. Drei vs. sechs Monate adjuvante Therapie beim Stadium-III-Kolonkarzinom. Onkologie 2022;28:937-939. [DOI: 10.1007/s00761-022-01215-7] [Reference Citation Analysis]
71 Li Y, Gu J, Yu Q. Efficacy of Mecobalamin Tablets Combined with Troxerutin in the Treatment of NSCLC Chemotherapy-Induced Peripheral Neuropathy. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-7. [DOI: 10.1155/2022/7946934] [Reference Citation Analysis]
72 Miguel CÁ, Noya-Riobó MV, Brumovsky PR, Villar MJ, Coronel MF. Sex-related differences in oxaliplatin-induced changes in the expression of transient receptor potential channels and their contribution to cold hypersensitivity. Neurosci Lett 2022;788:136863. [PMID: 36067900 DOI: 10.1016/j.neulet.2022.136863] [Reference Citation Analysis]
73 Mitin N, Nyrop KA, Strum SL, Knecht A, Carey LA, Reeder-Hayes KE, Claire Dees E, Jolly TA, Kimmick GG, Karuturi MS, Reinbolt RE, Speca JC, O'Hare EA, Muss HB. A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer. NPJ Breast Cancer 2022;8:103. [PMID: 36075910 DOI: 10.1038/s41523-022-00473-3] [Reference Citation Analysis]
74 Ballarini E, Malacrida A, Rodriguez-Menendez V, Pozzi E, Canta A, Chiorazzi A, Monza L, Semperboni S, Meregalli C, Carozzi VA, Hashemi M, Nicolini G, Scuteri A, Housley SN, Cavaletti G, Alberti P. Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? Int J Mol Sci 2022;23. [PMID: 36077454 DOI: 10.3390/ijms231710063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Bai LY, Li CP, Shan YS, Chuang SC, Chen JS, Chiang NJ, Chen YY, Tsou HH, Chuang MH, Chiu CF, Liu TW, Chen LT. A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma - The Taiwan Cooperative Oncology Group T1217 study. Eur J Cancer 2022;173:123-32. [PMID: 35932625 DOI: 10.1016/j.ejca.2022.06.043] [Reference Citation Analysis]
76 Balayssac D, Selvy M, Kerckhove N, Giraudet F, Collin A, Lolignier S, Wersinger E, Busserolles J. Chemotherapy-Induced Peripheral Neuropathy and New Therapeutic Targets: Preclinical Data of Drug Repositioning. Douleur analg 2022;35:137-143. [DOI: 10.3166/dea-2022-0222] [Reference Citation Analysis]
77 Clavo B, Rodríguez-abreu D, Galván S, Federico M, Martínez-sánchez G, Ramallo-fariña Y, Antonelli C, Benítez G, Rey-baltar D, Jorge IJ, Rodríguez-esparragón F, Serrano-aguilar P. Long-term improvement by ozone treatment in chronic pain secondary to chemotherapy-induced peripheral neuropathy: A preliminary report. Front Physiol 2022;13:935269. [DOI: 10.3389/fphys.2022.935269] [Reference Citation Analysis]
78 Mortensen C, Andersen NE, Stage TB. Bridging the Translational Gap in Chemotherapy-Induced Peripheral Neuropathy with iPSC-Based Modeling. Cancers 2022;14:3939. [DOI: 10.3390/cancers14163939] [Reference Citation Analysis]
79 Yang TT, Pai HC, Chen CY. Effect of cryotherapy on paclitaxel-induced peripheral neuropathy of the hand in female breast cancer patients: A prospective self-controlled study. Int J Nurs Pract 2022;:e13094. [PMID: 35971279 DOI: 10.1111/ijn.13094] [Reference Citation Analysis]
80 Engvall K, Gréen H, Fredrikson M, Lagerlund M, Lewin F, Åvall-Lundqvist E. Impact of persistent peripheral neuropathy on health-related quality of life among early-stage breast cancer survivors: a population-based cross-sectional study. Breast Cancer Res Treat 2022. [PMID: 35941422 DOI: 10.1007/s10549-022-06670-9] [Reference Citation Analysis]
81 Mine K, Kawashiri T, Inoue M, Kobayashi D, Mori K, Hiromoto S, Kudamatsu H, Uchida M, Egashira N, Koyanagi S, Ohdo S, Shimazoe T. Omeprazole Suppresses Oxaliplatin-Induced Peripheral Neuropathy in a Rodent Model and Clinical Database. Int J Mol Sci 2022;23. [PMID: 36012136 DOI: 10.3390/ijms23168859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 D’souza RS, Her YF, Jin MY, Morsi M, Abd-elsayed A. Neuromodulation Therapy for Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review. Biomedicines 2022;10:1909. [DOI: 10.3390/biomedicines10081909] [Reference Citation Analysis]
83 Nielsen SW, Hasselsteen SD, Dominiak HSH, Labudovic D, Reiter L, Dalton SO, Herrstedt J. Oral cannabidiol for prevention of acute and transient chemotherapy-induced peripheral neuropathy. Support Care Cancer 2022. [PMID: 35933415 DOI: 10.1007/s00520-022-07312-y] [Reference Citation Analysis]
84 Takasaki Y, Fujisawa T, Ushio M, Takahashi S, Yamagata W, Suzuki A, Ito K, Ochiai K, Tomishima K, Ishii S, Isayama H. Effect of Mirogabalin on Chemotherapy-Induced Peripheral Neuropathy Caused by Gemcitabine plus Nab-Paclitaxel Therapy in Pancreatic Cancer Patients: A Pilot Study. JVD 2022;1:36-42. [DOI: 10.3390/jvd1010005] [Reference Citation Analysis]
85 Knoerl R, Berry DL, Meyerhardt J, Reyes K, Salehi E, Gewandter JS. Exploring Patients' Understanding of Chemotherapy-Induced Peripheral Neuropathy. J Cancer Educ 2022. [PMID: 35927535 DOI: 10.1007/s13187-022-02206-3] [Reference Citation Analysis]
86 Tanay MAL, Armes J, Oakley C, Sage L, Tanner D, Roca J, Bryson L, Greenall B, Urwin L, Wyatt T, Robert G. Co-designing a cancer care intervention: reflections of participants and a doctoral researcher on roles and contributions. Res Involv Engagem 2022;8:36. [PMID: 35918715 DOI: 10.1186/s40900-022-00373-7] [Reference Citation Analysis]
87 Chen ZY, Liu Y, Wei Y, Deng LY, Zhang Q. Efficacy of Traditional Chinese Medicine Injection in Preventing Oxaliplatin-Induced Peripheral Neurotoxicity: An Analysis of Evidence from 3598 Patients. Evid Based Complement Alternat Med 2022;2022:6875253. [PMID: 35911148 DOI: 10.1155/2022/6875253] [Reference Citation Analysis]
88 Chen CS, Smith EML, Stringer KA, Henry NL, Hertz DL. Co-occurrence and metabolic biomarkers of sensory and motor subtypes of peripheral neuropathy from paclitaxel. Breast Cancer Res Treat 2022;194:551-60. [PMID: 35760975 DOI: 10.1007/s10549-022-06652-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Pérez-hernández C, Cánovas ML, Carmona-bayonas A, Escobar Y, Margarit C, Mulero Cervantes JF, Quintanar T, Serrano Alfonso A, Virizuela J. A Delphi Study on the Management of Neuropathic Cancer Pain in Spain: The DOLNEO Study. JPR 2022;Volume 15:2181-96. [DOI: 10.2147/jpr.s365351] [Reference Citation Analysis]
90 Marcotti A, Fernández-Trillo J, González A, Vizcaíno-Escoto M, Ros-Arlanzón P, Romero L, Vela JM, Gomis A, Viana F, de la Peña E. TRPA1 modulation by Sigma-1 receptor prevents oxaliplatin-induced painful peripheral neuropathy. Brain 2023;146:475-91. [PMID: 35871491 DOI: 10.1093/brain/awac273] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
91 Kanbayashi Y, Sakaguchi K, Ishikawa T, Tabuchi Y, Takagi R, Yokota I, Katoh N, Takayama K, Taguchi T. Predictors of the development of nab-paclitaxel-induced peripheral neuropathy in breast cancer patients: post hoc analysis of a prospective, phase II, self-controlled clinical trial. Med Oncol 2022;39:153. [PMID: 35852641 DOI: 10.1007/s12032-022-01754-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
92 Shin GJ, Abaci HE, Smith MC. Cellular Pathogenesis of Chemotherapy-Induced Peripheral Neuropathy: Insights From Drosophila and Human-Engineered Skin Models. Front Pain Res 2022;3. [DOI: 10.3389/fpain.2022.912977] [Reference Citation Analysis]
93 Wang FJ, Shi S, Wang YQ, Wang K, Fan SD, Zhang YN, Feng CC, Ju ZY. Protective Mechanism of Electroacupuncture on Peripheral Neurotoxicity Induced by Oxaliplatin in Rats. Chin J Integr Med 2022. [PMID: 35799085 DOI: 10.1007/s11655-022-2896-1] [Reference Citation Analysis]
94 Kerckhove N, Tougeron D, Lepage C, Pezet D, Le Malicot K, Pelkowski M, Pereira B, Balayssac D. Efficacy of donepezil for the treatment of oxaliplatin-induced peripheral neuropathy: DONEPEZOX, a protocol of a proof of concept, randomised, triple-blinded and multicentre trial. BMC Cancer 2022;22:742. [PMID: 35799138 DOI: 10.1186/s12885-022-09806-8] [Reference Citation Analysis]
95 Chung G, Kim SK. Therapeutics for Chemotherapy-Induced Peripheral Neuropathy: Approaches with Natural Compounds from Traditional Eastern Medicine. Pharmaceutics 2022;14:1407. [DOI: 10.3390/pharmaceutics14071407] [Reference Citation Analysis]
96 Greathouse KL, Wyatt M, Johnson AJ, Toy EP, Khan JM, Dunn K, Clegg DJ, Reddy S. Diet-microbiome interactions in cancer treatment: Opportunities and challenges for precision nutrition in cancer. Neoplasia 2022;29:100800. [DOI: 10.1016/j.neo.2022.100800] [Reference Citation Analysis]
97 Desai N, Arora N, Gupta A. Chemotherapy-Induced Peripheral Neuropathy. JAMA Intern Med 2022;182:766-7. [PMID: 35639389 DOI: 10.1001/jamainternmed.2022.1812] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
98 Park SB, Yoon J, Kim EH, Yoon SW. A Case Report of Chemotherapy-Induced Peripheral Neuropathy Treated with Modified <italic>Guibi-tang</italic>. J Int Korean Med 2022;43:451-459. [DOI: 10.22246/jikm.2022.43.3.451] [Reference Citation Analysis]
99 Rattanakrong N, Siriphorn A, Boonyong S. Incidence density and factors associated with peripheral neuropathy among women with breast cancer during taxane-based chemotherapy. Sci Rep 2022;12:10632. [PMID: 35739233 DOI: 10.1038/s41598-022-14870-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Crichton M, Yates PM, Agbejule OA, Spooner A, Chan RJ, Hart NH. Non-Pharmacological Self-Management Strategies for Chemotherapy-Induced Peripheral Neuropathy in People with Advanced Cancer: A Systematic Review and Meta-Analysis. Nutrients 2022;14:2403. [PMID: 35745132 DOI: 10.3390/nu14122403] [Reference Citation Analysis]
101 Kim S, Gang J, Lee JH, Yang H, Cheon C, Ko SG, Bae H, Kim W. [6]-Shogaol Attenuates Oxaliplatin-Induced Allodynia through Serotonergic Receptors and GABA in the Spinal Cord in Mice. Pharmaceuticals (Basel) 2022;15:726. [PMID: 35745645 DOI: 10.3390/ph15060726] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
102 Semis HS, Kandemir FM, Caglayan C, Kaynar O, Genc A, Arıkan SM. Protective effect of naringin against oxaliplatin-induced peripheral neuropathy in rats: A behavioral and molecular study. J Biochem Mol Toxicol 2022;:e23121. [PMID: 35670529 DOI: 10.1002/jbt.23121] [Reference Citation Analysis]
103 Karri J, Marathe A, Smith TJ, Wang EJ. The Use of Scrambler Therapy in Treating Chronic Pain Syndromes: A Systematic Review. Neuromodulation: Technology at the Neural Interface 2022. [DOI: 10.1016/j.neurom.2022.04.045] [Reference Citation Analysis]
104 Boden A. Cannabis thérapeutique : prise en charge de la douleur et autres symptômes du cancer. Douleurs : Évaluation - Diagnostic - Traitement 2022;23:144-150. [DOI: 10.1016/j.douler.2022.05.006] [Reference Citation Analysis]
105 Zhou X, Wang DY, Ding CY, Liu H, Sun ZQ. Psychosocial adaptation and influencing factors among patients with chemotherapy-induced peripheral neuropathy. World J Clin Cases 2022; 10(15): 4843-4855 [DOI: 10.12998/wjcc.v10.i15.4843] [Reference Citation Analysis]
106 Li T, Park SB, Battaglini E, King MT, Kiernan MC, Goldstein D, Rutherford C. Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use. Qual Life Res 2022. [PMID: 35596913 DOI: 10.1007/s11136-022-03154-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Chiang JCB, Arnold R, Dhanapalaratnam R, Markoulli M, Krishnan AV. Current and Emerging Pharmacotherapeutic Interventions for the Treatment of Peripheral Nerve Disorders. Pharmaceuticals 2022;15:607. [DOI: 10.3390/ph15050607] [Reference Citation Analysis]
108 Imbachí Salamanca AJ, Chito Castro KL, Orozco Burbano JD, Zamora Bastidas TO. Neuropatías periféricas, un enfoque multidimensional y práctico de una compleja condición. CES Med 2022;36:46-58. [DOI: 10.21615/cesmedicina.6250] [Reference Citation Analysis]
109 Yoshino T, Oki E, Misumi T, Kotaka M, Manaka D, Eto T, Hasegawa J, Takagane A, Nakamura M, Kato T, Munemoto Y, Nakamura F, Bando H, Taniguchi H, Sakamoto Y, Shiozawa M, Nishi M, Horiuchi T, Yamagishi H, Sakamoto J, Mizushima T, Ohtsu A, Mori M. Final Analysis of 3 Versus 6 Months of Adjuvant Oxaliplatin and Fluoropyrimidine-Based Therapy in Patients With Stage III Colon Cancer: The Randomized Phase III ACHIEVE Trial. J Clin Oncol 2022;:JCO2102628. [PMID: 35512259 DOI: 10.1200/JCO.21.02628] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 Knoerl R, Bockhoff J, Fox E, Giobbie-Hurder A, Berry DL, Berfield J, Meyerhardt J, Wright A, Ligibel J. Cancer Survivors' Perspectives of Virtual Yoga for Chronic Chemotherapy-Induced Peripheral Neuropathy Pain During the COVID-19 Pandemic. Comput Inform Nurs 2022;40:641-7. [PMID: 35930413 DOI: 10.1097/CIN.0000000000000937] [Reference Citation Analysis]
111 Adebayo OO, Dammer EB, Dill CD, Adebayo AO, Oseni SO, Griffen TL, Ohandjo AQ, Yan F, Jain S, Barwick BG, Singh R, Boise LH, Lillard, Jr. JW. Multivariant Transcriptome Analysis Identifies Modules and Hub Genes Associated with Poor Outcomes in Newly Diagnosed Multiple Myeloma Patients. Cancers 2022;14:2228. [DOI: 10.3390/cancers14092228] [Reference Citation Analysis]
112 Brinkmann V, Fritz G. Prevention of anticancer therapy-induced neurotoxicity: putting DNA damage in perspective. Neurotoxicology 2022:S0161-813X(22)00057-2. [PMID: 35487345 DOI: 10.1016/j.neuro.2022.04.009] [Reference Citation Analysis]
113 Liang ZJ, Tan J, Tang L, Xie ZB, Chen GJ, Liu GJ, Yuan L, Wang KX, Ding HP, Qiu H, Wang Q, Wang GF, Chen YL, Wang CH. NGF monoclonal antibody DS002 alleviates chemotherapy-induced peripheral neuropathy in rats. Acta Pharmacol Sin 2022. [PMID: 35468993 DOI: 10.1038/s41401-022-00904-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
114 Emery J, Butow P, Lai-Kwon J, Nekhlyudov L, Rynderman M, Jefford M. Management of common clinical problems experienced by survivors of cancer. Lancet 2022;399:1537-50. [PMID: 35430021 DOI: 10.1016/S0140-6736(22)00242-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 19.0] [Reference Citation Analysis]
115 Semochkin SV, Solovyev MV, Mendeleeva LP. Prevention and management of bortezomib-induced peripheral neuropathy in patients with multiple myeloma. Onkogematologiâ 2022;17:141-150. [DOI: 10.17650/1818-8346-2022-17-2-141-150] [Reference Citation Analysis]
116 Aghili M, Darzikolaee NM, Babaei M, Ghalehtaki R, Farhan F, Razavi SZE, Rezaei S, Esmati E, Samiei F, Azadvari M, Farazmand B, Bayani R, Amiri A. Duloxetine for the Prevention of Oxaliplatin Induced Peripheral Neuropathy: A Randomized, Placebo-Controlled, Double-blind Clinical Trial. J Gastrointest Cancer 2022. [PMID: 35426033 DOI: 10.1007/s12029-022-00824-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Mizrahi D, Goldstein D, Kiernan MC, Robinson L, Pitiyarachchi O, McCullough S, Mendoza-Jones P, Grimison P, Boyle F, Park SB. Development and consensus process for a clinical pathway for the assessment and management of chemotherapy-induced peripheral neuropathy. Support Care Cancer 2022. [PMID: 35394563 DOI: 10.1007/s00520-022-07024-3] [Reference Citation Analysis]
118 Wu C, Chan Y, Yen L, Chen Y, Lo C, Tseng L, Wang Y. Extremity Exercise Program in Breast Cancer Survivors Suffering from Chemotherapy-Induced Peripheral Neuropathy: A Feasibility Pilot Study. Healthcare 2022;10:688. [DOI: 10.3390/healthcare10040688] [Reference Citation Analysis]
119 Bérubé-Mercier P, Tapp D, Cimon MÈ, Li T, Park SB, Bouhêlier É, McGarragle K, Robichaud LA, Gewandter JS, Bouchard M, Gauthier LR. Evaluation of the psychometric properties of patient-reported and clinician-reported outcome measures of chemotherapy-induced peripheral neuropathy: a COSMIN systematic review protocol. BMJ Open 2022;12:e057950. [PMID: 35387828 DOI: 10.1136/bmjopen-2021-057950] [Reference Citation Analysis]
120 Fosså SD, Dahl AA, Thorsen L, Hellesnes R, Kiserud CE, Tandstad T, Brydøy M, Haugnes HS, Myklebust TÅ. Mortality and Second Cancer Incidence After Treatment for Testicular Cancer: Psychosocial Health and Lifestyle Are Modifiable Prognostic Factors. J Clin Oncol 2022;:JCO2102105. [PMID: 35380874 DOI: 10.1200/JCO.21.02105] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
121 Mazzotta M, Filetti M, Piras M, Mercadante S, Marchetti P, Giusti R. Patients' Satisfaction with Breakthrough Cancer Pain Therapy: A Secondary Analysis of IOPS-MS Study. Cancer Manag Res 2022;14:1237-45. [PMID: 35356594 DOI: 10.2147/CMAR.S353036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Casanova-mollà J. Chemotherapy-Induced Peripheral Neuropathy: Mechanisms and Clinical Assessment. Neurotoxicity - New Advances 2022. [DOI: 10.5772/intechopen.100495] [Reference Citation Analysis]
123 Pugh TM, Squarize F, Kiser AL. A Comprehensive Strategy to Pain Management for Cancer Patients in an Inpatient Rehabilitation Facility. Front Pain Res (Lausanne) 2021;2:688511. [PMID: 35295412 DOI: 10.3389/fpain.2021.688511] [Reference Citation Analysis]
124 Rodwin RL, Siddiq NZ, Ehrlich BE, Lustberg MB. Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions. Front Pain Res 2022;3:864910. [DOI: 10.3389/fpain.2022.864910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Sisignano M, Gribbon P, Geisslinger G. Drug Repurposing to Target Neuroinflammation and Sensory Neuron-Dependent Pain. Drugs 2022. [PMID: 35254645 DOI: 10.1007/s40265-022-01689-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
126 Szpejewska JE, Yilmaz M, Falkmer UG, Arendt-Nielsen L, Mørch CD. New diagnostic measures of oxaliplatin-induced peripheral sensory neuropathy. Cancer Treat Res Commun 2022;31:100543. [PMID: 35255440 DOI: 10.1016/j.ctarc.2022.100543] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Nielsen SW, Eckhoff L, Ruhlmann CHB, Herrstedt J, Dalton SO. The prevalence, distribution and impact of peripheral neuropathy among Danish patients with cancer - a population-based cross-sectional study. Acta Oncol 2022;61:363-70. [PMID: 34846991 DOI: 10.1080/0284186X.2021.2007283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Wang M, Yin Y, Yang H, Pei Z, Molassiotis A. Evaluating the safety, feasibility, and efficacy of non-invasive neuromodulation techniques in chemotherapy-induced peripheral neuropathy: A systematic review. European Journal of Oncology Nursing 2022. [DOI: 10.1016/j.ejon.2022.102124] [Reference Citation Analysis]
129 Desforges AD, Hebert CM, Spence AL, Reid B, Dhaibar HA, Cruz-topete D, Cornett EM, Kaye AD, Urits I, Viswanath O. Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: An update. Biomedicine & Pharmacotherapy 2022;147:112671. [DOI: 10.1016/j.biopha.2022.112671] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
130 Wang M, Pei Z, Molassiotis A. Recent advances in managing chemotherapy-induced peripheral neuropathy: A systematic review. European Journal of Oncology Nursing 2022. [DOI: 10.1016/j.ejon.2022.102134] [Reference Citation Analysis]
131 Gu J, Hu M, Gu Z, Yu J, Ji Y, Li L, Hu C, Wei G, Huo J. Bibliometric Analysis Reveals a 20-Year Research Trend for Chemotherapy-Induced Peripheral Neuropathy. Front Neurol 2021;12:793663. [PMID: 35211075 DOI: 10.3389/fneur.2021.793663] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
132 Chung KH, Park SB, Streckmann F, Wiskemann J, Mohile N, Kleckner AS, Colloca L, Dorsey SG, Kleckner IR. Mechanisms, Mediators, and Moderators of the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy. Cancers 2022;14:1224. [DOI: 10.3390/cancers14051224] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
133 Zahrieh D, Satele D, Smith EML, Loprinzi CL, Le-Rademacher J. Temporal, Location- and Symptom-Specific Likelihood of Patient-Reported Sensory Symptoms Related to Oxaliplatin-Induced Peripheral Neuropathy (OIPN) in Patients Receiving Oxaliplatin for Three Months. Cancers (Basel) 2022;14. [PMID: 35267520 DOI: 10.3390/cancers14051212] [Reference Citation Analysis]
134 Rattanakrong N, Promma N, Saraboon C, Waongenngarm P. Physical impairments, sensory disturbance, and functional ability in a cancer patient with and without chemotherapy-induced peripheral neuropathy symptoms. Support Care Cancer 2022. [PMID: 35217909 DOI: 10.1007/s00520-022-06927-5] [Reference Citation Analysis]
135 Sugimoto M, Takagi T, Suzuki R, Konno N, Asama H, Sato Y, Irie H, Okubo Y, Nakamura J, Takasumi M, Hashimoto M, Kato T, Kobashi R, Hikichi T, Ohira H. Drug treatment for chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer. Fukushima J Med Sci 2022. [PMID: 35197393 DOI: 10.5387/fms.2021-32] [Reference Citation Analysis]
136 Peng S, Ying AF, Chan NJH, Sundar R, Soon YY, Bandla A. Prevention of Oxaliplatin-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis. Front Oncol 2022;12:731223. [PMID: 35186722 DOI: 10.3389/fonc.2022.731223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
137 Ikio Y, Sagari A, Nakashima A, Matsuda D, Sawai T, Higashi T. Efficacy of combined hand exercise intervention in patients with chemotherapy-induced peripheral neuropathy: a pilot randomized controlled trial. Support Care Cancer. [DOI: 10.1007/s00520-022-06846-5] [Reference Citation Analysis]
138 Paton KF, Luo D, La Flamme AC, Prisinzano TE, Kivell BM. Sex Differences in Kappa Opioid Receptor Agonist Mediated Attenuation of Chemotherapy-Induced Neuropathic Pain in Mice. Front Pharmacol 2022;13:813562. [DOI: 10.3389/fphar.2022.813562] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Mitin N, Nyrop KA, Strum SL, Knecht A, Carey LA, Reeder-hayes KE, Dees EC, Jolly TA, Kimmick GG, Karuturi MS, Reinbolt RE, Speca JC, O’hare EA, Muss HB. A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer.. [DOI: 10.1101/2022.02.10.22270086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 Jones KF, Wechsler S, Zulewski D, Wood L. Pharmacological and Nonpharmacological Management of Chemotherapy-Induced Peripheral Neuropathy: A Scoping Review of Randomized Controlled Trials. J Palliat Med 2022. [PMID: 35128938 DOI: 10.1089/jpm.2021.0512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
141 Shi DD, Guo JA, Hoffman HI, Su J, Mino-Kenudson M, Barth JL, Schenkel JM, Loeffler JS, Shih HA, Hong TS, Wo JY, Aguirre AJ, Jacks T, Zheng L, Wen PY, Wang TC, Hwang WL. Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunities. Lancet Oncol 2022;23:e62-74. [PMID: 35114133 DOI: 10.1016/S1470-2045(21)00596-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
142 Xu X, Jia L, Ma X, Li H, Sun C. Application Potential of Plant-Derived Medicines in Prevention and Treatment of Platinum-Induced Peripheral Neurotoxicity. Front Pharmacol 2021;12:792331. [PMID: 35095502 DOI: 10.3389/fphar.2021.792331] [Reference Citation Analysis]
143 Brett Whalen L, Zachary Wright W, Kundur P, Angadi S, Modesitt SC. Beneficial effects of exercise on chemotherapy-induced peripheral neuropathy and sleep disturbance: A review of literature and proposed mechanisms. Gynecologic Oncology Reports 2022;39:100927. [DOI: 10.1016/j.gore.2022.100927] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
144 Lee JH, Kim B, Ko S, Kim W. Analgesic Effect of SH003 and Trichosanthes kirilowii Maximowicz in Paclitaxel-Induced Neuropathic Pain in Mice. CIMB 2022;44:718-30. [DOI: 10.3390/cimb44020050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
145 Giraudet F, Selvy M, Kerckhove N, Pereira B, Barreau F, Nguyen D, Busserolles J, Cabrespine A, Chaleteix C, Soubrier M, Bay J, Lemal R, Balayssac D. Relation between auditory difficulties and bortezomib-induced peripheral neuropathy in multiple myeloma: a single-center cross-sectional study. Eur Arch Otorhinolaryngol. [DOI: 10.1007/s00405-021-07234-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Lee YC, King MT, O'Connell RL, Lanceley A, Joly F, Hilpert F, Davis A, Roncolato FT, Okamoto A, Bryce J, Donnellan P, Oza AM, Avall-Lundqvist E, Berek JS, Ledermann JA, Berton D, Sehouli J, Feeney A, Kaminsky MC, Diamante K, Stockler MR, Friedlander ML; GCIG Symptom Benefit Group. Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study. Int J Gynecol Cancer 2022:ijgc-2021-003142. [PMID: 35086926 DOI: 10.1136/ijgc-2021-003142] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
147 Wang M, Molassiotis A. Mapping chemotherapy-induced peripheral neuropathy phenotype and health-related quality of life in patients with cancer through exploratory analysis of multimodal assessment data. Support Care Cancer. [DOI: 10.1007/s00520-022-06821-0] [Reference Citation Analysis]
148 Tofthagen C, Tanay M, Perlman A, Starr J, Advani P, Sheffield K, Brigham T. A Systematic Review of Nutritional Lab Correlates with Chemotherapy Induced Peripheral Neuropathy. J Clin Med 2022;11:355. [PMID: 35054049 DOI: 10.3390/jcm11020355] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
149 Goodenough CG, Diouf B, Yang W, Sapkota Y, Finch ER, Lu L, Partin RE, Wogksch MD, Hudson MM, Robison LL, Wang Z, Jeha S, Evans WE, Ness KK. Association between CEP72 genotype and persistent neuropathy in survivors of childhood acute lymphoblastic leukemia. Leukemia 2022. [PMID: 34980876 DOI: 10.1038/s41375-021-01484-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
150 Coolbrandt A, Vancoille K, Dejaeger E, Peeters H, Laenen A, Neven P, Punie K, Wildiers H. Preventing taxane-related peripheral neuropathy, pain and nail toxicity: a prospective self-controlled trial comparing hilotherapy with frozen gloves in early breast cancer. Breast Cancer Res Treat 2022. [PMID: 34982322 DOI: 10.1007/s10549-021-06477-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
151 Park SB, Tamburin S, Schenone A, Kleckner IR, Velasco R, Alberti P, Kanzawa-Lee G, Lustberg M, Dorsey SG, Mantovani E, Hamedani M, Argyriou AA, Cavaletti G, Hoke A; Toxic Neuropathy Consortium. Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinion. Expert Rev Neurother 2022;22:65-76. [PMID: 34894974 DOI: 10.1080/14737175.2022.2018300] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
152 张 瑾. Prevention and Treatment Measures Related to Peripheral Neuropathy Caused by Paclitaxel-Based Chemotherapy Drugs in Breast Cancer Patients. ACM 2022;12:6377-6383. [DOI: 10.12677/acm.2022.127919] [Reference Citation Analysis]
153 Yogendran LV, Ernstoff MS, Fadul CE. Neurologic complications associated with genitourinary cancer. Neurological Complications of Systemic Cancer and Antineoplastic Therapy 2022. [DOI: 10.1016/b978-0-12-821976-8.00001-3] [Reference Citation Analysis]
154 Mezzanotte JN, Grimm M, Shinde NV, Nolan T, Worthen-Chaudhari L, Williams NO, Lustberg MB. Updates in the Treatment of Chemotherapy-Induced Peripheral Neuropathy. Curr Treat Options Oncol 2022;23:29-42. [PMID: 35167004 DOI: 10.1007/s11864-021-00926-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
155 Kahn AM, Blenman KR, Sonis ST, Lustberg MB. Strategies to mitigate the toxicity of cancer therapeutics. Advances in Cancer Research 2022. [DOI: 10.1016/bs.acr.2022.02.006] [Reference Citation Analysis]
156 Hiramoto S, Asano H, Miyamoto T, Takegami M, Kawabata A. Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan. PLoS One 2021;16:e0261473. [PMID: 34972132 DOI: 10.1371/journal.pone.0261473] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
157 Han X, Matsuda N, Matsuda K, Yamanaka M, Suzuki I. An <i>in vitro</i> microfluidic culture device for peripheral neurotoxicity prediction at low concentrations based on deep learning. Fundam Toxicol Sci 2022;9:203-209. [DOI: 10.2131/fts.9.203] [Reference Citation Analysis]
158 Chen Z, Malkin MG. Chemotherapy-induced peripheral neuropathy. Neurological Complications of Systemic Cancer and Antineoplastic Therapy 2022. [DOI: 10.1016/b978-0-12-821976-8.00022-0] [Reference Citation Analysis]
159 Youssef G, Wen PY, Lee EQ. Neurological complications of systemic cancer and antineoplastic therapy. Neurological Complications of Systemic Cancer and Antineoplastic Therapy 2022. [DOI: 10.1016/b978-0-12-821976-8.00015-3] [Reference Citation Analysis]
160 Pannullo SC, Zhou ZN, Rivera M, Odigie E, Balogun O, Noch EK, Ivanidze J, Moliterno J, Chapman-davis E. Neurological complications of gynecological cancers. Neurological Complications of Systemic Cancer and Antineoplastic Therapy 2022. [DOI: 10.1016/b978-0-12-821976-8.00007-4] [Reference Citation Analysis]
161 Joy L, Jolien R, Marithé C, Stijn E, Laura S, Hilde L, Sandra B, Wendy N, Ruth H, Liesbeth R, Sylvana S, Sylvia H, Jeroen M. The use of photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled pilot trial (NEUROLASER trial). Support Care Cancer 2022;30:5509-17. [PMID: 35312857 DOI: 10.1007/s00520-022-06975-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
162 Bonhof CS, van de Poll-Franse LV, de Hingh IH, Vreugdenhil G, Mols F. Mindfulness is associated with severity of peripheral neuropathy and related patient-reported outcomes among colorectal cancer patients. Support Care Cancer 2022;30:9517-26. [PMID: 36030458 DOI: 10.1007/s00520-022-07340-8] [Reference Citation Analysis]
163 Behrouzi A, Fehrenbacher JC. Chemotherapy-Induced Peripheral Neuropathy. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00109-2] [Reference Citation Analysis]
164 Miyamoto T, Domoto R, Sekiguchi F, Kamaguchi R, Nishimura R, Matsuno M, Tsubota M, Fujitani M, Hatanaka S, Koizumi Y, Wang D, Nishibori M, Kawabata A. Development of hepatic impairment aggravates chemotherapy-induced peripheral neuropathy following oxaliplatin treatment: Evidence from clinical and preclinical studies. Journal of Pharmacological Sciences 2022. [DOI: 10.1016/j.jphs.2022.01.006] [Reference Citation Analysis]
165 Budhu JA, Wen PY, Lee EQ. Neurologic complications of oncologic therapy. Handbook of Neuro-Oncology Neuroimaging 2022. [DOI: 10.1016/b978-0-12-822835-7.00013-5] [Reference Citation Analysis]
166 Enßle JC. Peripheres Nervensystem. Therapie-Handbuch - Onkologie und Hämatologie 2022. [DOI: 10.1016/b978-3-437-23824-6.00016-x] [Reference Citation Analysis]
167 Sharma A, Johnson KB, Bie B, Rhoades EE, Sen A, Kida Y, Hockings J, Gatta A, Davenport J, Arcangelini C, Ritzu J, DeVecchio J, Hughen R, Wei M, Thomas Budd G, Lynn Henry N, Eng C, Foss J, Rotroff DM. A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol. Technol Cancer Res Treat 2022;21:15330338221127169. [PMID: 36172750 DOI: 10.1177/15330338221127169] [Reference Citation Analysis]
168 Knoerl R, Berry D, Meyerhardt JA, Reyes K, Salehi E, Thornton K, Gewandter JS. Identifying participants' preferences for modifiable chemotherapy-induced peripheral neuropathy prevention clinical trial factors: an adaptive choice-based conjoint analysis. Support Care Cancer 2022;30:9963-73. [PMID: 36355216 DOI: 10.1007/s00520-022-07447-y] [Reference Citation Analysis]
169 Knoerl R, Mazzola E, Hong F, Salehi E, McCleary N, Ligibel J, Reyes K, Berry DL. Self-Reported Severity, Characteristics, and Functional Limitations of Chemotherapy-Induced Peripheral Neuropathy. Pain Manag Nurs 2021:S1524-9042(21)00247-2. [PMID: 34972658 DOI: 10.1016/j.pmn.2021.11.010] [Reference Citation Analysis]
170 Tamburin S, Park SB, Schenone A, Mantovani E, Hamedani M, Alberti P, Yildiz-Kabak V, Kleckner IR, Kolb N, Mazzucchelli M, McNeish B, Argyriou AA, Cavaletti G, Hoke A; Toxic Neuropathy Consortium. Rehabilitation, exercise, and related non-pharmacological interventions for chemotherapy-induced peripheral neurotoxicity: systematic review and evidence-based recommendations. Crit Rev Oncol Hematol 2021;:103575. [PMID: 34968623 DOI: 10.1016/j.critrevonc.2021.103575] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
171 Lamoine S, Cumenal M, Barriere DA, Pereira V, Fereyrolles M, Prival L, Barbier J, Boudieu L, Brasset E, Bertin B, Renaud Y, Miot-Noirault E, Civiale MA, Balayssac D, Aissouni Y, Eschalier A, Busserolles J. The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice. Int J Mol Sci 2021;23:98. [PMID: 35008525 DOI: 10.3390/ijms23010098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
172 Housley SN, Nardelli P, Rotterman TM, Cope TC. Neural circuit mechanisms of sensorimotor disability in cancer treatment. Proc Natl Acad Sci U S A 2021;118:e2100428118. [PMID: 34911753 DOI: 10.1073/pnas.2100428118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
173 Domoto R, Sekiguchi F, Kamaguchi R, Iemura M, Yamanishi H, Tsubota M, Wang D, Nishibori M, Kawabata A. Role of neuron-derived ATP in paclitaxel-induced HMGB1 release from macrophages and peripheral neuropathy. J Pharmacol Sci 2022;148:156-61. [PMID: 34924121 DOI: 10.1016/j.jphs.2021.11.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
174 Jia J, Guo Y, Sundar R, Bandla A, Hao Z. Cryotherapy for Prevention of Taxane-Induced Peripheral Neuropathy: A Meta-Analysis. Front Oncol 2021;11:781812. [PMID: 34912720 DOI: 10.3389/fonc.2021.781812] [Reference Citation Analysis]
175 Sugimoto M, Takagi T, Suzuki R, Konno N, Asama H, Sato Y, Irie H, Okubo Y, Nakamura J, Takasumi M, Hashimoto M, Kato T, Kobashi R, Hikichi T, Ohira H. Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients. BMC Cancer 2021;21:1319. [PMID: 34886831 DOI: 10.1186/s12885-021-09069-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
176 Egashira N. Pathological Mechanisms and Preventive Strategies of Oxaliplatin-Induced Peripheral Neuropathy. Front Pain Res 2021;2. [DOI: 10.3389/fpain.2021.804260] [Reference Citation Analysis]
177 Velasco R, Domingo-Domenech E, Sureda A. Brentuximab-Induced Peripheral Neurotoxicity: A Multidisciplinary Approach to Manage an Emerging Challenge in Hodgkin Lymphoma Therapy. Cancers (Basel) 2021;13:6125. [PMID: 34885234 DOI: 10.3390/cancers13236125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
178 Yamamoto S, Egashira N. Lipid signaling in chemotherapy-induced peripheral neuropathy. Current Opinion in Toxicology 2021;28:1-6. [DOI: 10.1016/j.cotox.2021.08.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
179 Gupta E, Lee C, Ng A, Bruera E. Pain relief with elastic therapeutic taping. BMJ Support Palliat Care 2021:bmjspcare-2021-003381. [PMID: 34853128 DOI: 10.1136/bmjspcare-2021-003381] [Reference Citation Analysis]
180 Lee EQ. Neurologic Complications of Cancer Therapies. Curr Neurol Neurosci Rep 2021;21:66. [PMID: 34817688 DOI: 10.1007/s11910-021-01151-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
181 Kerckhove N, Selvy M, Lambert C, Gonneau C, Feydel G, Pétorin C, Vimal-Baguet A, Melnikov S, Kullab S, Hebbar M, Bouché O, Slimano F, Bourgeois V, Lebrun-Ly V, Thuillier F, Mazard T, Tavan D, Benmammar KE, Monange B, Ramdani M, Péré-Vergé D, Huet-Penz F, Bedjaoui A, Genty F, Leyronnas C, Busserolles J, Trévis S, Pinon V, Pezet D, Balayssac D. Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients' Profiles With Oxaliplatin-Induced Peripheral Neuropathy. Front Pharmacol 2021;12:744085. [PMID: 34803689 DOI: 10.3389/fphar.2021.744085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
182 Huh G, Lee HS, Choi JH, Lee SH, Paik WH, Ryu JK, Kim YT, Bang S, Lee ES. Gemcitabine plus Nab-paclitaxel as a second-line treatment following FOLFIRINOX failure in advanced pancreatic cancer: a multicenter, single-arm, open-label, phase 2 trial. Ther Adv Med Oncol 2021;13:17588359211056179. [PMID: 34790261 DOI: 10.1177/17588359211056179] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
183 Eldridge S, Scuteri A, Jones EMC, Cavaletti G, Guo L, Glaze E. Considerations for a Reliable In Vitro Model of Chemotherapy-Induced Peripheral Neuropathy. Toxics 2021;9:300. [PMID: 34822690 DOI: 10.3390/toxics9110300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
184 Wu S, Bai X, Guo C, Huang Z, Ouyang H, Huang J, Zeng W. Ganglioside-monosialic acid (GM1) for prevention of chemotherapy-induced peripheral neuropathy: a meta-analysis with trial sequential analysis. BMC Cancer 2021;21:1173. [PMID: 34727879 DOI: 10.1186/s12885-021-08884-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
185 Saito Y, Takekuma Y, Furuta M, Sugawara M. Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report. Case Rep Oncol 2021;14:1418-21. [PMID: 34720951 DOI: 10.1159/000518776] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
186 Binder J, Unver E, Clayton J, Burke P, Paxman R, Sundar R, Bandla A. A Limb Hypothermia Wearable for Chemotherapy-Induced Peripheral Neuropathy: A Mixed-Methods Approach in Medical Product Development. Front Digit Health 2020;2:573234. [PMID: 34713046 DOI: 10.3389/fdgth.2020.573234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
187 van Haren F, van den Heuvel S, Ligtenberg M, Vissers K, Steegers M. Diagnostic tools should be used for the diagnosis of chemotherapy induced peripheral neuropathy in breast cancer patients receiving taxanes. Cancer Rep (Hoboken) 2021;:e1577. [PMID: 34687287 DOI: 10.1002/cnr2.1577] [Reference Citation Analysis]
188 Thomaier L, Darst BF, Jewett P, Hoffmann C, Brown K, Makaram A, Blaes A, Argenta P, Teoh D, Vogel RI. Genetic variants predictive of chemotherapy-induced peripheral neuropathy symptoms in gynecologic cancer survivors. Gynecol Oncol 2021;163:578-82. [PMID: 34674889 DOI: 10.1016/j.ygyno.2021.10.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
189 Yang Y, Zhao B, Gao X, Sun J, Ye J, Li J, Cao P. Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development. J Exp Clin Cancer Res 2021;40:331. [PMID: 34686205 DOI: 10.1186/s13046-021-02141-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
190 Cavaletti G, Marmiroli P, Renn CL, Dorsey SG, Serra MP, Quartu M, Meregalli C. Cannabinoids: an Effective Treatment for Chemotherapy-Induced Peripheral Neurotoxicity? Neurotherapeutics 2021. [PMID: 34668147 DOI: 10.1007/s13311-021-01127-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
191 Burgess J, Ferdousi M, Gosal D, Boon C, Matsumoto K, Marshall A, Mak T, Marshall A, Frank B, Malik RA, Alam U. Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment. Oncol Ther 2021;9:385-450. [PMID: 34655433 DOI: 10.1007/s40487-021-00168-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
192 Gu Z, Wei G, Zhu L, Zhu L, Hu J, Li Q, Cai G, Lu H, Liu M, Chen C, Ji Y, Li G, Huo J. Preventive Efficacy and Safety of Yiqi-Wenjing-Fang Granules on Oxaliplatin-Induced Peripheral Neuropathy: A Protocol for a Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. Evid Based Complement Alternat Med 2021;2021:5551568. [PMID: 34630609 DOI: 10.1155/2021/5551568] [Reference Citation Analysis]
193 Hunter LA, Soares HP. Quality of Life and Symptom Management in Advanced Biliary Tract Cancers. Cancers (Basel) 2021;13:5074. [PMID: 34680223 DOI: 10.3390/cancers13205074] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
194 Meregalli C, Maricich Y, Cavaletti G, Canta A, Carozzi VA, Chiorazzi A, Newbold E, Marmiroli P, Ceresa C, Diani A, Papapetropoulos S, Lee MS. Reversal of Bortezomib-Induced Neurotoxicity by Suvecaltamide, a Selective T-Type Ca-Channel Modulator, in Preclinical Models. Cancers (Basel) 2021;13:5013. [PMID: 34638498 DOI: 10.3390/cancers13195013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
195 Wellenberg A, Brinkmann V, Bornhorst J, Ventura N, Honnen S, Fritz G. Cisplatin-induced neurotoxicity involves the disruption of serotonergic neurotransmission. Pharmacol Res 2021;174:105921. [PMID: 34601079 DOI: 10.1016/j.phrs.2021.105921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
196 Yokoyama S, Nakagawa C, Hosomi K. Treatment strategy of oxaliplatin-induced peripheral neuropathy: a retrospective, nationwide study. Support Care Cancer 2022;30:1765-73. [PMID: 34595605 DOI: 10.1007/s00520-021-06585-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
197 Tsubota M, Miyazaki T, Ikeda Y, Hayashi Y, Aokiba Y, Tomita S, Sekiguchi F, Wang D, Nishibori M, Kawabata A. Caspase-Dependent HMGB1 Release from Macrophages Participates in Peripheral Neuropathy Caused by Bortezomib, a Proteasome-Inhibiting Chemotherapeutic Agent, in Mice. Cells 2021;10:2550. [PMID: 34685531 DOI: 10.3390/cells10102550] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
198 Knoerl R, Mazzola E, Mitchell SA, Hong F, Salehi E, McCleary N, Ligibel JA, Reyes K, Berry DL. Measurement properties of brief neuropathy screening items in cancer patients receiving taxanes, platinums, or proteasome inhibitors. J Patient Rep Outcomes 2021;5:101. [PMID: 34568984 DOI: 10.1186/s41687-021-00377-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
199 Ilari S, Lauro F, Giancotti LA, Malafoglia V, Dagostino C, Gliozzi M, Condemi A, Maiuolo J, Oppedisano F, Palma E, Tomino C, Salvemini D, Mollace V, Muscoli C. The Protective Effect of Bergamot Polyphenolic Fraction (BPF) on Chemotherapy-Induced Neuropathic Pain. Pharmaceuticals (Basel) 2021;14:975. [PMID: 34681199 DOI: 10.3390/ph14100975] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
200 Gauthier LR, Robichaud L, Bouffard M, Therrien F, Béland S, Bouvrette M, Gewandter J, Gagliese L, Dworkin RH, Lemieux J, Savard J, Jackson PL, Aubin M, Lauzier S, Gagnon B, Dionne A, Shobbrook C, Gagnon P. Factors associated with chemotherapy-induced peripheral neuropathy-related reduced taxane dose or premature discontinuation in women with early-stage breast cancer.. [DOI: 10.1101/2021.09.13.21263539] [Reference Citation Analysis]
201 Cabric V, Harrison R, Gauthier LR, Graham CA, Gagliese L. How do we measure the adequacy of cancer pain management? Testing the performance of 4 commonly used measures and steps towards measurement refinement.. [DOI: 10.1101/2021.09.13.21263529] [Reference Citation Analysis]
202 Knoerl R, Giobbie-Hurder A, Berfield J, Berry D, Meyerhardt JA, Wright AA, Ligibel JA. Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial. J Cancer Surviv 2021. [PMID: 34524631 DOI: 10.1007/s11764-021-01081-z] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
203 Tsai CH, Lin YH, Li YS, Ho TL, Hoai Thuong LH, Liu YH. Integrated Medicine for Chemotherapy-Induced Peripheral Neuropathy. Int J Mol Sci 2021;22:9257. [PMID: 34502166 DOI: 10.3390/ijms22179257] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
204 Huang CC, Ho TJ, Ho HY, Chen PY, Tu CH, Huang YC, Lee YC, Sun MF, Chen YH. Acupuncture Relieved Chemotherapy-Induced Peripheral Neuropathy in Patients with Breast Cancer: A Pilot Randomized Sham-Controlled Trial. J Clin Med 2021;10:3694. [PMID: 34441990 DOI: 10.3390/jcm10163694] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
205 Kawashiri T, Inoue M, Mori K, Kobayashi D, Mine K, Ushio S, Kudamatsu H, Uchida M, Egashira N, Shimazoe T. Preclinical and Clinical Evidence of Therapeutic Agents for Paclitaxel-Induced Peripheral Neuropathy. Int J Mol Sci 2021;22:8733. [PMID: 34445439 DOI: 10.3390/ijms22168733] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
206 Lee JH, Kim W. Involvement of Serotonergic System in Oxaliplatin-Induced Neuropathic Pain. Biomedicines 2021;9:970. [PMID: 34440174 DOI: 10.3390/biomedicines9080970] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
207 Bonomo P, Stocchi G, Caini S, Desideri I, Santarlasci V, Becherini C, Limatola V, Locatello LG, Mannelli G, Spinelli G, Guido C, Livi L. Acupuncture for radiation-induced toxicity in head and neck squamous cell carcinoma: a systematic review based on PICO criteria. Eur Arch Otorhinolaryngol 2021. [PMID: 34331571 DOI: 10.1007/s00405-021-07002-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
208 Drat-Gzubicka J, Pyszora A, Budzyński J, Currow D, Krajnik M. Is Neuropathic Pain a Good Marker of Peripheral Neuropathy in Hospice Patients with Advanced Cancer? The Single Center Pilot Study. Diagnostics (Basel) 2021;11:1377. [PMID: 34441311 DOI: 10.3390/diagnostics11081377] [Reference Citation Analysis]
209 Liu Z, Wang Y, Shan F, Ying X, Zhang Y, Li S, Jia Y, Miao R, Xue K, Li Z, Li Z, Ji J. Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy. Ann Surg Oncol 2021. [PMID: 34327603 DOI: 10.1245/s10434-021-10087-x] [Reference Citation Analysis]
210 Bouchenaki H, Danigo A, Bernard A, Bessaguet F, Richard L, Sturtz F, Balayssac D, Magy L, Demiot C. Ramipril Alleviates Oxaliplatin-Induced Acute Pain Syndrome in Mice. Front Pharmacol 2021;12:712442. [PMID: 34349658 DOI: 10.3389/fphar.2021.712442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
211 Velasco R, Alemany M, Villagrán M, Argyriou AA. Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity. J Pers Med 2021;11:669. [PMID: 34357136 DOI: 10.3390/jpm11070669] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
212 Hill BL, Alldredge J. An Overview of Chemotherapy-Induced Peripheral Neuropathy Resulting from Regimens Used in Gynecologic Malignancies. Indian J Gynecol Oncolog 2021;19. [DOI: 10.1007/s40944-021-00564-2] [Reference Citation Analysis]
213 Pro S, Vinti L, Boni A, Mastronuzzi A, Scilipoti M, Velardi M, Caroleo AM, Farina E, Badolato F, Alessi I, Di Nardo G, Carai A, Valeriani M, Reale A, Parisi P, Raucci U. Peripheral Nervous System Involvement in Non-Primary Pediatric Cancer: From Neurotoxicity to Possible Etiologies. J Clin Med 2021;10:3016. [PMID: 34300182 DOI: 10.3390/jcm10143016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
214 Eikeland SA, Smeland KB, Mols F, Fagerli UM, Bersvendsen HS, Kiserud CE, Fosså A. Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin's lymphoma; symptom burden and quality of life. Acta Oncol 2021;60:911-20. [PMID: 33905285 DOI: 10.1080/0284186X.2021.1917776] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
215 Kleckner IR, Jusko TA, Culakova E, Chung K, Kleckner AS, Asare M, Inglis JE, Loh KP, Peppone LJ, Miller J, Melnik M, Kasbari S, Ossip D, Mustian KM. Longitudinal study of inflammatory, behavioral, clinical, and psychosocial risk factors for chemotherapy-induced peripheral neuropathy. Breast Cancer Res Treat 2021;189:521-32. [PMID: 34191201 DOI: 10.1007/s10549-021-06304-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
216 Sałat K, Furgała-Wojas A, Sałat R. The Microglial Activation Inhibitor Minocycline, Used Alone and in Combination with Duloxetine, Attenuates Pain Caused by Oxaliplatin in Mice. Molecules 2021;26:3577. [PMID: 34208184 DOI: 10.3390/molecules26123577] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
217 Omran M, Belcher EK, Mohile NA, Kesler SR, Janelsins MC, Hohmann AG, Kleckner IR. Review of the Role of the Brain in Chemotherapy-Induced Peripheral Neuropathy. Front Mol Biosci 2021;8:693133. [PMID: 34179101 DOI: 10.3389/fmolb.2021.693133] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
218 Swaminathan G, Shigna A, Kumar A, Byroju VV, Durgempudi VR, Dinesh Kumar L. RNA Interference and Nanotechnology: A Promising Alliance for Next Generation Cancer Therapeutics. Front Nanotechnol 2021;3:694838. [DOI: 10.3389/fnano.2021.694838] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
219 Gu J, Lu H, Chen C, Gu Z, Hu M, Liu L, Yu J, Wei G, Huo J. Diabetes mellitus as a risk factor for chemotherapy-induced peripheral neuropathy: a meta-analysis. Support Care Cancer 2021. [PMID: 34085148 DOI: 10.1007/s00520-021-06321-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
220 Hung HW, Liu CY, Chen HF, Chang CC, Chen SC. Impact of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life in Patients with Advanced Lung Cancer Receiving Platinum-Based Chemotherapy. Int J Environ Res Public Health 2021;18:5677. [PMID: 34073174 DOI: 10.3390/ijerph18115677] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
221 Chen J, Shan H, Yang W, Zhang J, Dai H, Ye Z. Vitamin E for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: A meta-Analysis. Front Pharmacol 2021;12:684550. [PMID: 34054560 DOI: 10.3389/fphar.2021.684550] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
222 Rimola V, Osthues T, Königs V, Geißlinger G, Sisignano M. Oxaliplatin Causes Transient Changes in TRPM8 Channel Activity. Int J Mol Sci 2021;22:4962. [PMID: 34066977 DOI: 10.3390/ijms22094962] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
223 Catalano M, Aprile G, Ramello M, Conca R, Petrioli R, Roviello G. Association between Low-Grade Chemotherapy-Induced Peripheral Neuropathy (CINP) and Survival in Patients with Metastatic Adenocarcinoma of the Pancreas. J Clin Med 2021;10:1846. [PMID: 33922821 DOI: 10.3390/jcm10091846] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
224 Selvy M, Kerckhove N, Pereira B, Barreau F, Nguyen D, Busserolles J, Giraudet F, Cabrespine A, Chaleteix C, Soubrier M, Bay JO, Lemal R, Balayssac D. Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study. Front Pharmacol 2021;12:637593. [PMID: 33967771 DOI: 10.3389/fphar.2021.637593] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
225 Clavo B, Martínez-Sánchez G, Rodríguez-Esparragón F, Rodríguez-Abreu D, Galván S, Aguiar-Bujanda D, Díaz-Garrido JA, Cañas S, Torres-Mata LB, Fabelo H, Téllez T, Santana-Rodríguez N, Fernández-Pérez L, Marrero-Callico G. Modulation by Ozone Therapy of Oxidative Stress in Chemotherapy-Induced Peripheral Neuropathy: The Background for a Randomized Clinical Trial. Int J Mol Sci 2021;22:2802. [PMID: 33802143 DOI: 10.3390/ijms22062802] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
226 Knoerl R, Mazzola E, Hong F, Salehi E, McCleary N, Ligibel J, Reyes K, Berry DL. Exploring the impact of a decision support algorithm to improve clinicians' chemotherapy-induced peripheral neuropathy assessment and management practices: a two-phase, longitudinal study. BMC Cancer 2021;21:236. [PMID: 33676431 DOI: 10.1186/s12885-021-07965-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
227 Licht T, Keilani M, Crevenna R. Chemotherapy-induced peripheral neuropathy (CIPN). memo 2021;14:34-8. [DOI: 10.1007/s12254-021-00688-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
228 Timmins HC, Li T, Goldstein D, Trinh T, Mizrahi D, Harrison M, Horvath LG, Friedlander M, Kiernan MC, Park SB. The impact of obesity on neuropathy outcomes for paclitaxel- and oxaliplatin-treated cancer survivors. J Cancer Surviv. [DOI: 10.1007/s11764-021-01012-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
229 Kwon BI, Woo Y, Kim J. Review of Experimental Researches on Bee Venom Pharmacopuncture Therapy for Chemotherapy-induced Peripheral Neuropathy. kjopp 2021;35:1-7. [DOI: 10.15188/kjopp.2021.02.35.1.1] [Reference Citation Analysis]
230 Acklin S, Xia F. The Role of Nucleotide Excision Repair in Cisplatin-Induced Peripheral Neuropathy: Mechanism, Prevention, and Treatment. Int J Mol Sci 2021;22:1975. [PMID: 33671279 DOI: 10.3390/ijms22041975] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
231 Li Y, Lustberg MB, Hu S. Emerging Pharmacological and Non-Pharmacological Therapeutics for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy. Cancers (Basel) 2021;13:766. [PMID: 33673136 DOI: 10.3390/cancers13040766] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
232 Timmins HC, Li T, Trinh T, Kiernan MC, Harrison M, Boyle F, Friedlander M, Goldstein D, Park SB. Weekly Paclitaxel-Induced Neurotoxicity in Breast Cancer: Outcomes and Dose Response. Oncologist 2021;26:366-74. [PMID: 33523545 DOI: 10.1002/onco.13697] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
233 Waissengrin B, Mirelman D, Pelles S, Bukstein F, Blumenthal DT, Wolf I, Geva R. Effect of cannabis on oxaliplatin-induced peripheral neuropathy among oncology patients: a retrospective analysis. Ther Adv Med Oncol 2021;13:1758835921990203. [PMID: 33613702 DOI: 10.1177/1758835921990203] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
234 Hellriegel M, Emons G. Supportive Maßnahmen in der gynäkologischen Onkologie. Frauenheilkunde up2date 2021;15:83-96. [DOI: 10.1055/a-1068-7402] [Reference Citation Analysis]
235 Kawashiri T, Mine K, Kobayashi D, Inoue M, Ushio S, Uchida M, Egashira N, Shimazoe T. Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence. Int J Mol Sci 2021;22. [PMID: 33573316 DOI: 10.3390/ijms22031393] [Reference Citation Analysis]
236 Kawashiri T, Mine K, Kobayashi D, Inoue M, Ushio S, Uchida M, Egashira N, Shimazoe T. Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence. IJMS 2021;22:1393. [DOI: 10.3390/ijms22031393] [Cited by in Crossref: 9] [Article Influence: 4.5] [Reference Citation Analysis]
237 Kawashiri T, Mine K, Kobayashi D, Inoue M, Ushio S, Uchida M, Egashira N, Shimazoe T. Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence. Int J Mol Sci 2021;22:1393. [PMID: 33573316 DOI: 10.3390/ijms22031393] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
238 Yamamoto S, Egashira N. Pathological Mechanisms of Bortezomib-Induced Peripheral Neuropathy. Int J Mol Sci 2021;22:E888. [PMID: 33477371 DOI: 10.3390/ijms22020888] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
239 Yamamoto S, Egashira N. Drug Repositioning for the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: A Mechanism- and Screening-Based Strategy. Front Pharmacol 2020;11:607780. [PMID: 33519471 DOI: 10.3389/fphar.2020.607780] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
240 Hertz DL. Exploring pharmacogenetics of paclitaxel- and docetaxel-induced peripheral neuropathy by evaluating the direct pharmacogenetic-pharmacokinetic and pharmacokinetic-neuropathy relationships. Expert Opin Drug Metab Toxicol 2021;17:227-39. [PMID: 33401943 DOI: 10.1080/17425255.2021.1856367] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
241 Kleckner IR, Park SB, Streckmann F, Wiskemann J, Hardy S, Mohile N. Systematic Review of Exercise for Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy. Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy 2021. [DOI: 10.1007/978-3-030-78663-2_8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
242 Alberti P, Steer CB. Prevention of Chemotherapy-Induced Peripheral Neuropathy (CIPN): Current Clinical Data and Future Directions. Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy 2021. [DOI: 10.1007/978-3-030-78663-2_5] [Reference Citation Analysis]
243 Mayo S, Toh YL, Oh J, Chan A. Pharmacological Treatment of Established Chemotherapy-Induced Peripheral Neuropathy. Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy 2021. [DOI: 10.1007/978-3-030-78663-2_7] [Reference Citation Analysis]
244 Kleckner IR, Park SB, Streckmann F, Wiskemann J, Hardy S, Mohile N. Clinical and Practical Recommendations in the Use of Exercise, Physical Therapy, and Occupational Therapy for Chemotherapy-Induced Peripheral Neuropathy. Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy 2021. [DOI: 10.1007/978-3-030-78663-2_9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
245 Argyriou AA, Desai A, Loprinzi C. Natural History of Chemotherapy-Induced Peripheral Neuropathy. Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy 2021. [DOI: 10.1007/978-3-030-78663-2_1] [Reference Citation Analysis]
246 Moore H, Anders C, Patel MP, Fras AM, Slawson K. Neuropathy. Common Issues in Breast Cancer Survivors 2021. [DOI: 10.1007/978-3-030-75377-1_8] [Reference Citation Analysis]
247 Cho Y, Ruddy KJ, Lavoie Smith EM. Evaluation of Chemotherapy-Induced Peripheral Neuropathy. Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy 2021. [DOI: 10.1007/978-3-030-78663-2_3] [Reference Citation Analysis]
248 Ishiguro H, Ishibashi H, Yamaguchi T, Watanuki N, Hanai A, Sakurai N, Tsuji T. Provisional Clinical Opinions Recommended by the Supportive and Palliative Care Working Group for Vulnerable Elderly Patients with Colorectal Cancer. Journal of Japan Society of Coloproctology 2021;74:349-356. [DOI: 10.3862/jcoloproctology.74.349] [Reference Citation Analysis]
249 Zheng JY, Mixon AC, McLarney MD. Safety, Precautions, and Modalities in Cancer Rehabilitation: an Updated Review. Curr Phys Med Rehabil Rep 2021;9:142-53. [PMID: 34178432 DOI: 10.1007/s40141-021-00312-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
250 Sekiguchi F, Kawabata A. Role of HMGB1 in Chemotherapy-Induced Peripheral Neuropathy. Int J Mol Sci 2020;22:E367. [PMID: 33396481 DOI: 10.3390/ijms22010367] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
251 Ng DQ, Tan CJ, Soh BC, Tan MML, Loh SY, Tan YE, Ong HH, Teng PPC, Chan JJ, Chay WY, Lee J, Lai G, Beh SY, Tan TJY, Yap YS, Lee GE, Wong M, Dent R, Lo YL, Chan A, Loh KW. Impact of Cryotherapy on Sensory, Motor, and Autonomic Neuropathy in Breast Cancer Patients Receiving Paclitaxel: A Randomized, Controlled Trial. Front Neurol. 2020;11:604688. [PMID: 33424755 DOI: 10.3389/fneur.2020.604688] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
252 Miura Y, Ando M, Yamazaki K, Hironaka S, Boku N, Muro K, Hyodo I. Time-dependent discrepancies between physician-assessed and patient-reported oxaliplatin-induced peripheral neuropathy in patients with metastatic colorectal cancer who received mFOLFOX6 plus bevacizumab: a post hoc analysis (WJOG4407GSS2). Support Care Cancer 2021;29:3715-23. [PMID: 33200233 DOI: 10.1007/s00520-020-05891-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
253 Antonuzzo A, Bossi P, Cortinovis D. Elapsed time for an unresolved adverse event: systemic anticancer therapy-induced neurotoxicity calls for action. Annals of Oncology 2020;31:1289-1290. [DOI: 10.1016/j.annonc.2020.08.2103] [Reference Citation Analysis]
254 Akhter T, Pervin S, Goodman A. Quality of Life in Ovarian-Cancer Patients Receiving Chemotherapy. JCT 2020;11:695-714. [DOI: 10.4236/jct.2020.1111059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]